Hisar : An investigation into the death of 66 children in the Gambia from the cough syrup of Kundli-based Maiden Pharmaceutical Ltd in Sonepat district has revealed that the company had exported 4 types of medicine to Gambia, two of which were even before permission was granted to manufacture the formulation.
Not only this, a lot of flaws have also been found in making BMR (Batch Manufacturing Record) and many other irregularities have also been found.
Maiden Pharmaceutical Ltd was inspected by a team of Central Drugs Standard Control Organization (CDSCO) drug inspectors Sandeep Kumar, Devendra Pratap Singh and Panipat SDCO Rakesh Dahiya after the matter came to light. These defects were found during inspection.
According to the report, Kofexmalin Baby Cough Syrup and MaGrip n Cold Syrup were exported earlier, while permission to manufacture the same was taken later.
In this case, Panipat’s advocate Yashpal had sent a complaint to PM Modi, accusing Haryana FDA’s state drug controller Manmohan Taneja of changing cough syrup samples by taking a bribe of Rs 5 crore from the owner of the company.
The PMO has forwarded it to the Chief Secretary, Government of Haryana for appropriate action.
FDA’s Deputy State Drug Controller Lalit Kumar Goel called the complainant for investigation, but the complainant did not join the investigation, saying it was futile to conduct an investigation by a junior officer against a senior officer.
Contacted Manmohan Taneja in the matter and sent a text message, but he did not present his stand.
